Correlation Between Cytek Biosciences and Omeros
Can any of the company-specific risk be diversified away by investing in both Cytek Biosciences and Omeros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytek Biosciences and Omeros into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytek Biosciences and Omeros, you can compare the effects of market volatilities on Cytek Biosciences and Omeros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytek Biosciences with a short position of Omeros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytek Biosciences and Omeros.
Diversification Opportunities for Cytek Biosciences and Omeros
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cytek and Omeros is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and Omeros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omeros and Cytek Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytek Biosciences are associated (or correlated) with Omeros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omeros has no effect on the direction of Cytek Biosciences i.e., Cytek Biosciences and Omeros go up and down completely randomly.
Pair Corralation between Cytek Biosciences and Omeros
If you would invest 0.00 in Omeros on October 20, 2024 and sell it today you would earn a total of 0.00 from holding Omeros or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 5.0% |
Values | Daily Returns |
Cytek Biosciences vs. Omeros
Performance |
Timeline |
Cytek Biosciences |
Omeros |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Good
Cytek Biosciences and Omeros Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cytek Biosciences and Omeros
The main advantage of trading using opposite Cytek Biosciences and Omeros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytek Biosciences position performs unexpectedly, Omeros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will offset losses from the drop in Omeros' long position.Cytek Biosciences vs. Orthopediatrics Corp | Cytek Biosciences vs. Electromed | Cytek Biosciences vs. Pulmonx Corp | Cytek Biosciences vs. Rxsight |
Omeros vs. Crinetics Pharmaceuticals | Omeros vs. Enanta Pharmaceuticals | Omeros vs. Amicus Therapeutics | Omeros vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |